Eruptive cherry angiomas developing in a patient treated with ramucirumab

Acta Oncol. 2018 May;57(5):709-711. doi: 10.1080/0284186X.2017.1410287. Epub 2017 Nov 30.

Authors

Pablo Espinosa Lara¹, Camino Medina-Puente², Alejandro Riquelme Oliveira³, José Jiménez-Reyes⁴

Affiliations

¹ a Skin Cancer and Cutaneous Toxicities of Cancer Therapy Unit, Department of Dermatology , Hospital Universitario Infanta Cristina , Parla , Madrid , Spain.
² b Department of Pathology , Hospital Universitario Infanta Cristina , Parla , Madrid , Spain.
³ c Department of Medical Oncology , Hospital Universitario Infanta Cristina , Parla , Madrid , Spain.
⁴ d Department of Dermatology , Hospital Universitario Infanta Cristina , Parla , Madrid , Spain.

PMID: 29188737
DOI: 10.1080/0284186X.2017.1410287

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma / pathology
Aged
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Drug Eruptions / pathology*
Exanthema / chemically induced
Exanthema / pathology
Hemangioma / chemically induced*
Hemangioma / pathology
Humans
Liver Neoplasms / drug therapy
Liver Neoplasms / secondary
Male
Paclitaxel / administration & dosage
Peritoneal Neoplasms / drug therapy
Peritoneal Neoplasms / secondary
Ramucirumab
Stomach Neoplasms / drug therapy*
Stomach Neoplasms / pathology
Withholding Treatment

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Paclitaxel